These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 31501523)

  • 1. Loss of TRIM29 suppresses cancer stem cell-like characteristics of PDACs via accelerating ISG15 degradation.
    Sun J; Yan J; Qiao HY; Zhao FY; Li C; Jiang JY; Liu BQ; Meng XN; Wang HQ
    Oncogene; 2020 Jan; 39(3):546-559. PubMed ID: 31501523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BAG3 deletion suppresses stem cell-like features of pancreatic ductal adenocarcinoma via translational suppression of ISG15.
    Li XY; Yan J; Sun J; Li C; Jiang JY; Wang JM; Meng XN; Liang JJ; Wang HQ
    Biochim Biophys Acta Mol Cell Res; 2019 May; 1866(5):819-827. PubMed ID: 30771383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ISG15 is downregulated by KLF12 and implicated in maintenance of cancer stem cell-like features in cisplatin-resistant ovarian cancer.
    Zhang Q; Wang J; Qiao H; Huyan L; Liu B; Li C; Jiang J; Zhao F; Wang H; Yan J
    J Cell Mol Med; 2021 May; 25(9):4395-4407. PubMed ID: 33797839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRIM29 as a novel biomarker in pancreatic adenocarcinoma.
    Sun H; Dai X; Han B
    Dis Markers; 2014; 2014():317817. PubMed ID: 24864129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ISG15 pathway knockdown reverses pancreatic cancer cell transformation and decreases murine pancreatic tumor growth via downregulation of PDL-1 expression.
    Burks J; Fleury A; Livingston S; Smith JP
    Cancer Immunol Immunother; 2019 Dec; 68(12):2029-2039. PubMed ID: 31709456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ISG15 and ISGylation is required for pancreatic cancer stem cell mitophagy and metabolic plasticity.
    Alcalá S; Sancho P; Martinelli P; Navarro D; Pedrero C; Martín-Hijano L; Valle S; Earl J; Rodríguez-Serrano M; Ruiz-Cañas L; Rojas K; Carrato A; García-Bermejo L; Fernández-Moreno MÁ; Hermann PC; Sainz B
    Nat Commun; 2020 May; 11(1):2682. PubMed ID: 32472071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Covalent ISG15 conjugation to CHIP promotes its ubiquitin E3 ligase activity and inhibits lung cancer cell growth in response to type I interferon.
    Yoo L; Yoon AR; Yun CO; Chung KC
    Cell Death Dis; 2018 Jan; 9(2):97. PubMed ID: 29367604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRIM29 regulates the SETBP1/SET/PP2A axis via transcription factor VEZF1 to promote progression of ovarian cancer.
    Qiao HY; Zhang Q; Wang JM; Jiang JY; Huyan LY; Yan J; Li C; Wang HQ
    Cancer Lett; 2022 Mar; 529():85-99. PubMed ID: 34973391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. m6A-YTHDF1-mediated TRIM29 upregulation facilitates the stem cell-like phenotype of cisplatin-resistant ovarian cancer cells.
    Hao L; Wang JM; Liu BQ; Yan J; Li C; Jiang JY; Zhao FY; Qiao HY; Wang HQ
    Biochim Biophys Acta Mol Cell Res; 2021 Jan; 1868(1):118878. PubMed ID: 33011193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemosensitivity is controlled by p63 modification with ubiquitin-like protein ISG15.
    Jeon YJ; Jo MG; Yoo HM; Hong SH; Park JM; Ka SH; Oh KH; Seol JH; Jung YK; Chung CH
    J Clin Invest; 2012 Jul; 122(7):2622-36. PubMed ID: 22706304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ISG15 predicts poor prognosis and promotes cancer stem cell phenotype in nasopharyngeal carcinoma.
    Chen RH; Du Y; Han P; Wang HB; Liang FY; Feng GK; Zhou AJ; Cai MY; Zhong Q; Zeng MS; Huang XM
    Oncotarget; 2016 Mar; 7(13):16910-22. PubMed ID: 26919245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Negative regulation of ISG15 E3 ligase EFP through its autoISGylation.
    Zou W; Wang J; Zhang DE
    Biochem Biophys Res Commun; 2007 Mar; 354(1):321-7. PubMed ID: 17222803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ISG15 is a critical microenvironmental factor for pancreatic cancer stem cells.
    Sainz B; Martín B; Tatari M; Heeschen C; Guerra S
    Cancer Res; 2014 Dec; 74(24):7309-20. PubMed ID: 25368022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E3 ubiquitin ligase TRIM29 promotes pancreatic cancer growth and progression via stabilizing Yes-associated protein 1.
    Deng X; Fu X; Teng H; Fang L; Liang B; Zeng R; Chen L; Zou Y
    J Transl Med; 2021 Aug; 19(1):332. PubMed ID: 34353343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Free ISG15 triggers an antitumor immune response against breast cancer: a new perspective.
    Burks J; Reed RE; Desai SD
    Oncotarget; 2015 Mar; 6(9):7221-31. PubMed ID: 25749047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ISG15 suppresses translation of ABCC2 via ISGylation of hnRNPA2B1 and enhances drug sensitivity in cisplatin resistant ovarian cancer cells.
    Wang JM; Liu BQ; Zhang Q; Hao L; Li C; Yan J; Zhao FY; Qiao HY; Jiang JY; Wang HQ
    Biochim Biophys Acta Mol Cell Res; 2020 Apr; 1867(4):118647. PubMed ID: 31926942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UBL4A inhibits autophagy-mediated proliferation and metastasis of pancreatic ductal adenocarcinoma via targeting LAMP1.
    Chen H; Li L; Hu J; Zhao Z; Ji L; Cheng C; Zhang G; Zhang T; Li Y; Chen H; Pan S; Sun B
    J Exp Clin Cancer Res; 2019 Jul; 38(1):297. PubMed ID: 31288830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RIG-I regulates myeloid differentiation by promoting TRIM25-mediated ISGylation.
    Wu SF; Xia L; Shi XD; Dai YJ; Zhang WN; Zhao JM; Zhang W; Weng XQ; Lu J; Le HY; Tao SC; Zhu J; Chen Z; Wang YY; Chen S
    Proc Natl Acad Sci U S A; 2020 Jun; 117(25):14395-14404. PubMed ID: 32513696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
    Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
    J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different roles for two ubiquitin-like domains of ISG15 in protein modification.
    Chang YG; Yan XZ; Xie YY; Gao XC; Song AX; Zhang DE; Hu HY
    J Biol Chem; 2008 May; 283(19):13370-7. PubMed ID: 18356159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.